Abstract:
Sanofi Sidi Abdellah employees face significant health risks due to exposure to hazardous chemicals such as Active Pharmaceutical Ingredients (APIs) and Carcinogenic, Mutagenic, and Reproductive toxicants (CMRs). Current risk assessment practices lack a systematic approach for prioritizing chemical hazards, leading to inefficiencies in implementing control measures and standardizing operating procedures.
The present work aims to conduct a NIOSH qualitative chemical risk assessment at Sanofi’s Sidi Abdellah site to identify, prioritize, and manage chemical risks associated with inhalation and dermal exposure. This assessment will guide the development of an action plan, including prioritized quantitative assessments, control measures, and standardized SOPs.
